Product Stewardship

Blood lead monitoring

Lead is hazardous to health, but if handled correctly lead sheet is not a risk during its manufacture or to installers.

In order to ensure that workers are not exposed to harmful levels of lead,  regular lead-in-blood monitoring is advised and indeed is a mandatory legal requirement in all European countries if exposure to lead is possible.

The results of lead-in-blood monitoring can also provide companies with information on past exposure and help identify improvements in work practices to minimise an individual’s exposure in future.

ELSIA member companies comply with National Occupational Exposure Limits (OEL’s) and the current REACH Derived No Effect Level (DNEL) of 40mcg/dl blood for male employees.   ELSIA is also committed to a culture of continuous improvement in blood lead so it has recently adopted a voluntary target of 30 mcg/dl to be achieved by all ELSIA member company employees by the end of 2016.